Aurinia Pharmaceuticals
AUPH
AUPH
239 hedge funds and large institutions have $726M invested in Aurinia Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 61 increasing their positions, 89 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.74% more ownership
Funds ownership: 43.17% → 49.91% (+6.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
31% less repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 89
Holders
239
Holding in Top 10
1
Calls
$16.1M
Puts
$8.82M
Top Buyers
| 1 | +$25.4M | |
| 2 | +$15.2M | |
| 3 | +$14.4M | |
| 4 |
Two Sigma Investments
New York
|
+$13M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$9.06M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$5.57M | |
| 3 | -$4.97M | |
| 4 |
Lazard Asset Management
New York
|
-$4.9M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$3.64M |
